TerminatedPhase 3Phase 4ACTRN12611000387921

The role of intravenous iron for patients with anaemia around the time of surgery

The role of intravenous iron compared to standard treatment for patients booked for major abdominal surgery with anaemia around the time of surgery in reduction in allogeneic red cell transfusion".


Sponsor

Lyell McEwin Hospital

Enrollment

136 participants

Start Date

Aug 27, 2011

Study Type

Interventional

Conditions

Summary

investigators decided to decline the sponsorship offer.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria4

  • Anaemia
  • Hb, Ferritin <300 micro g/L
  • female<120 gram/L, Transferrin Sat <25%
  • male<130 gram/L

Exclusion Criteria5

  • Other causes of anaemia – haemaglobinopahty, GI bleeding, acute systemic infection, vitamin B12 or folate deficiency, hepatitis, HIV
  • No consent
  • Severe asthma
  • Allergy to iron
  • Pre-treatment ferritin levels > 300 ng/ml

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients randomized to the intervention group will be exposed to intravenenous admistration of Ferric carboxymaltose before (1000mg or max 15mg /kg) and after surgery (50mg per 100ml estimated blood l

Patients randomized to the intervention group will be exposed to intravenenous admistration of Ferric carboxymaltose before (1000mg or max 15mg /kg) and after surgery (50mg per 100ml estimated blood loss)


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000387921


Related Trials